Aura Biosciences (AURA) Financials: Revenue & Earnings
$663.71M
Market Cap
—
P/E
—
Forward P/E
—
Score
AURA price $6.40 +0.10 +1.59%
AURA fair value Not meaningful. Price $6.40.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Not meaningful. The model is more than 80% below the live price, which happens for unprofitable or very early companies and is not a price target.
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-05 | — | -0.37 | — | — |
| 2026-08-11 | -0.48 | -0.38 | — | — |
| 2026-05-11 | -0.50 | -0.40 | — | — |
| 2026-03-30 | -0.37 | -0.43 | — | — |
| 2025-11-13 | -0.40 | -0.46 | — | — |
| 2025-08-13 | -0.47 | -0.49 | — | — |
| 2025-05-15 | -0.55 | -0.47 | — | — |
| 2025-03-24 | -0.52 | -0.43 | — | — |
| 2024-11-12 | -0.42 | -0.44 | — | — |
| 2024-08-08 | -0.41 | -0.45 | — | — |
| 2024-05-09 | -0.40 | -0.51 | — | — |
| 2024-03-27 | -0.50 | -0.39 | 2.06M | — |
| 2023-11-09 | -0.48 | -0.54 | — | — |
| 2023-08-09 | -0.48 | -0.49 | — | — |
| 2023-05-11 | -0.46 | -0.52 | — | — |
| 2023-03-15 | -0.52 | -0.58 | — | — |
| 2022-11-10 | -0.53 | -0.52 | — | — |
| 2022-08-11 | -0.46 | -0.46 | — | — |
| 2022-05-12 | -0.44 | -0.44 | — | — |
| 2022-03-23 | -2.51 | -0.39 | — | — |
| 2021-11-24 | -0.32 | — | — | — |
| 2021-11-01 | -0.45 | — | — | — |
| 2021-03-31 | -0.30 | — | — | — |
| 2020-12-31 | -0.25 | — | — | — |
| 2020-09-30 | -0.19 | — | — | — |
| 2020-06-30 | -0.22 | — | — | — |
| 2020-03-31 | -0.27 | — | — | — |
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-09-01 | Person Julie | Buy | 212.39K | $7.43 | 1.58M |
| 2026-09-01 | Person Julie | Buy | 107.61K | — | — |
| 2026-09-01 | Kratz Erica | Buy | 199.12K | $7.43 | 1.48M |
| 2026-09-01 | Kratz Erica | Buy | 100.89K | — | — |
| 2026-09-01 | Hopkins Janet Jill | Buy | 58.85K | — | — |
| 2026-09-01 | Hopkins Janet Jill | Buy | 116.15K | $7.43 | 862.99K |
| 2026-09-01 | Elazzouzi Amy | Buy | 23.54K | — | — |
| 2026-09-01 | Elazzouzi Amy | Buy | 46.46K | $7.43 | 345.20K |
| 2026-09-01 | Abu-Absi Susan | Buy | 265.49K | $7.43 | 1.97M |
| 2026-09-01 | Abu-Absi Susan | Buy | 134.51K | — | — |
| 2026-08-12 | Person Julie | Other | 0 | — | — |
| 2026-08-10 | Kratz Erica | Other | 0 | — | — |
| 2026-08-10 | Abu-Absi Susan | Other | 0 | — | — |
| 2026-07-07 | Bender Jeremy | Buy | 60.00K | $7.03 | 421.80K |
| 2026-07-07 | Bender Jeremy | Buy | 30.00K | — | — |
| 2026-07-07 | Bender Jeremy | Other | 0 | — | — |
| 2026-07-01 | Kilroy Conor | Buy | 14.86K | — | — |
| 2026-06-16 | Gibney Anthony S | Sell | 12.82K | $6.42 | 82.33K |
| 2026-06-11 | Bitetti Teresa Marie | Buy | 15.00K | — | — |
| 2026-06-11 | Bitetti Teresa Marie | Buy | 30.00K | $6.21 | 186.30K |
| 2026-06-11 | Srivastava Sapna | Buy | 15.00K | — | — |
| 2026-06-11 | Srivastava Sapna | Buy | 30.00K | $6.21 | 186.30K |
| 2026-06-11 | Johnson David Michael | Buy | 15.00K | — | — |
| 2026-06-11 | Johnson David Michael | Buy | 30.00K | $6.21 | 186.30K |
| 2026-06-11 | Mattessich Antony C. | Buy | 15.00K | — | — |
| 2026-06-11 | Mattessich Antony C. | Buy | 30.00K | $6.21 | 186.30K |
| 2026-05-19 | Holles Natalie C. | Buy | 2.17M | $7.39 | 16.03M |
| 2026-05-19 | Holles Natalie C. | Buy | 553.84K | — | — |
| 2026-05-19 | Holles Natalie C. | Buy | 600.12K | — | — |
| 2026-05-07 | Matrix Capital Management Company, LP | Sell | 6.92M | $5.64 | 39.04M |
| 2026-04-30 | Holles Natalie C. | Other | 0 | — | — |
| 2026-04-16 | Kilroy Conor | Sell | 11.74K | $7.02 | 82.40K |
| 2026-03-02 | Kilroy Conor | Buy | 62.34K | — | — |
| 2026-03-02 | Kilroy Conor | Buy | 112.66K | $6.14 | 691.74K |
| 2026-03-02 | Gibney Anthony S | Buy | 71.25K | — | — |
| 2026-03-02 | Gibney Anthony S | Buy | 128.75K | $6.14 | 790.56K |
| 2026-03-02 | de los Pinos Elisabet | Buy | 166.00K | — | — |
| 2026-03-02 | de los Pinos Elisabet | Buy | 249.00K | $6.14 | 1.53M |
| 2026-03-02 | Plavsic Mark | Buy | 62.34K | — | — |
| 2026-03-02 | Plavsic Mark | Buy | 112.66K | $6.14 | 691.74K |
| 2026-03-02 | Hopkins Janet Jill | Buy | 89.06K | — | — |
| 2026-03-02 | Hopkins Janet Jill | Buy | 160.94K | $6.14 | 988.20K |
| 2026-03-02 | Elazzouzi Amy | Buy | 44.53K | — | — |
| 2026-03-02 | Elazzouzi Amy | Buy | 80.47K | $6.14 | 494.10K |
| 2026-02-17 | Kilroy Conor | Sell | 12.08K | $5.05 | 61.00K |
| 2026-02-17 | Plavsic Mark | Sell | 15.89K | $5.05 | 80.24K |
| 2026-02-17 | Hopkins Janet Jill | Sell | 20.40K | $5.06 | 103.23K |
| 2026-02-17 | Elazzouzi Amy | Sell | 8.55K | $5.06 | 43.26K |
| 2026-02-17 | de los Pinos Elisabet | Sell | 47.65K | $5.06 | 241.10K |
| 2026-01-20 | Elazzouzi Amy | Sell | 1.58K | $4.86 | 7.68K |
| 2026-01-20 | de los Pinos Elisabet | Sell | 16.93K | $4.86 | 82.27K |
| 2025-11-17 | Hopkins Janet Jill | Sell | 17.11K | $5.42 | 92.73K |
| 2025-10-29 | Elazzouzi Amy | Sell | 896 | $6.35 | 5.69K |
| 2025-10-29 | de los Pinos Elisabet | Sell | 9.05K | $6.35 | 57.46K |
| 2025-10-16 | Plavsic Mark | Sell | 12.17K | $6.35 | 77.27K |
| 2025-08-18 | Elazzouzi Amy | Buy | 2.32K | $4.25 | 9.86K |
| 2025-08-18 | Elazzouzi Amy | Buy | 1.09K | $3.16 | 3.46K |
| 2025-08-18 | Elazzouzi Amy | Buy | 4.74K | $2.74 | 13.00K |
| 2025-08-18 | Elazzouzi Amy | Sell | 7.72K | $6.70 | 51.74K |
| 2025-08-18 | Elazzouzi Amy | Buy | 547 | $5.21 | 2.85K |
| 2025-08-18 | Elazzouzi Amy | Buy | 547 | $5.48 | 3.00K |
| 2025-08-18 | Elazzouzi Amy | Buy | 1.09K | $5.48 | 6.00K |
| 2025-08-18 | Elazzouzi Amy | Buy | 2.55K | $5.07 | 12.95K |
| 2025-08-18 | Elazzouzi Amy | Sell | 547 | $5.21 | 2.85K |
| 2025-08-18 | Elazzouzi Amy | Sell | 2.32K | $4.25 | 9.86K |
| 2025-08-18 | Elazzouzi Amy | Sell | 4.74K | $2.74 | 13.00K |
| 2025-08-18 | Elazzouzi Amy | Sell | 2.55K | $5.07 | 12.95K |
| 2025-08-18 | Elazzouzi Amy | Sell | 547 | $5.48 | 3.00K |
| 2025-08-18 | Elazzouzi Amy | Sell | 1.09K | $3.16 | 3.46K |
| 2025-06-17 | Srivastava Sapna | Buy | 13.00K | — | — |
| 2025-06-17 | Srivastava Sapna | Buy | 17.00K | $6.18 | 105.06K |
| 2025-06-17 | Johnson David Michael | Buy | 13.00K | — | — |
| 2025-06-17 | Johnson David Michael | Buy | 17.00K | $6.18 | 105.06K |
| 2025-06-17 | Mattessich Antony C. | Buy | 13.00K | — | — |
| 2025-06-17 | Mattessich Antony C. | Buy | 17.00K | $6.18 | 105.06K |
| 2025-06-02 | Gibney Anthony S | Buy | 250.00K | $6.16 | 1.54M |
| 2025-06-02 | Gibney Anthony S | Buy | 150.00K | — | — |
| 2025-06-02 | de los Pinos Elisabet | Buy | 10.95K | $5.07 | 55.51K |
| 2025-06-02 | de los Pinos Elisabet | Sell | 9.95K | $6.16 | 61.28K |
| 2025-06-02 | de los Pinos Elisabet | Sell | 10.95K | $5.07 | 55.51K |
| 2025-05-16 | Johnson David Michael | Buy | 20.00K | $4.90 | 98.00K |
| 2025-05-16 | Johnson David Michael | Buy | 5.00K | $4.90 | 24.50K |
| 2025-05-16 | Gibney Anthony S | Buy | 50.00K | $4.90 | 245.00K |
| 2025-05-16 | Gibney Anthony S | Sell | 1.52K | $5.15 | 7.82K |
| 2025-05-16 | Gibney Anthony S | Buy | 12.50K | $4.90 | 61.25K |
| 2025-05-13 | Gibney Anthony S | Other | 0 | — | — |
| 2025-05-13 | Gibney Anthony S | Other | 5.00K | $7.21 | 36.05K |
| 2025-04-16 | Elazzouzi Amy | Sell | 897 | $5.49 | 4.92K |
| 2025-04-16 | Kilroy Conor | Sell | 7.16K | $5.49 | 39.32K |
| 2025-03-31 | Bitetti Teresa Marie | Buy | 29.00K | $5.86 | 169.94K |
| 2025-03-31 | Bitetti Teresa Marie | Buy | 21.00K | — | — |
| 2025-03-31 | Bitetti Teresa Marie | Other | 0 | — | — |
| 2025-02-18 | Plavsic Mark | Sell | 2.15K | $7.75 | 16.67K |
| 2025-02-18 | Elazzouzi Amy | Sell | 1.40K | $7.75 | 10.88K |
| 2025-02-18 | Hopkins Janet Jill | Sell | 2.53K | $7.75 | 19.64K |
| 2025-02-18 | de los Pinos Elisabet | Sell | 20.22K | $7.75 | 156.80K |
| 2025-02-03 | de los Pinos Elisabet | Buy | 194.32K | — | — |
| 2025-02-03 | de los Pinos Elisabet | Buy | 255.68K | $7.68 | 1.96M |
| 2025-02-03 | Plavsic Mark | Buy | 90.47K | — | — |
| 2025-02-03 | Plavsic Mark | Buy | 59.52K | $7.68 | 457.15K |
Latest filed quarter: Q2 2026.
Institutions holding: 151, holders +24 vs prior quarter. Ownership 100.73%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| TCG CROSSOVER MANAGEMENT, LLC | 9.53M | 9.53M | New | 67.69M |
| MONTANOVA CAPITAL, LLC | 7.21M | 2.83M | +64.79% | 51.16M |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 7.10M | 2.00M | +39.22% | 50.41M |
| LONG FOCUS CAPITAL MANAGEMENT, LLC | 5.12M | 500.00K | +10.82% | 36.35M |
| BLACKROCK, INC. | 4.71M | 1.12M | +31.26% | 33.42M |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4.64M | -241.12K | -4.94% | 32.94M |
| CALIGAN PARTNERS LP | 4.30M | 4.07M | +1769.91% | 30.52M |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.10M | 1.86M | +82.74% | 29.11M |
| FCPM III SERVICES B.V. | 4.05M | 4.05M | New | 28.78M |
| ORBIMED ADVISORS LLC | 3.33M | 3.33M | New | 23.67M |
| MEDICXI VENTURES MANAGEMENT (JERSEY) LTD | 3.04M | 0 | 0.00% | 21.58M |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 2.95M | 833.33K | +39.35% | 20.95M |
| JUPITER TOPCO LLC | 2.50M | 2.50M | New | 17.79M |
| RA CAPITAL MANAGEMENT, L.P. | 2.50M | 2.50M | New | 17.75M |
| BALYASNY ASSET MANAGEMENT L.P. | 2.35M | 1.80M | +322.24% | 16.72M |
| FRANKLIN TEMPLETON INC | 2.07M | 0 | 0.00% | 14.72M |
| GEODE CAPITAL MANAGEMENT, LLC | 1.75M | 443.86K | +33.86% | 12.46M |
| REDMILE GROUP, LLC | 1.67M | 1.67M | New | 11.83M |
| ECOR1 CAPITAL, LLC | 1.67M | 1.67M | New | 11.83M |
| TRAILS EDGE CAPITAL PARTNERS, LP | 1.44M | 1.44M | New | 10.25M |
| FORESITE CAPITAL MANAGEMENT VI LLC | 1.33M | 1.33M | New | 9.47M |
| STATE STREET CORP | 1.22M | 258.31K | +26.78% | 8.68M |
| WOODLINE PARTNERS LP | 1.21M | 1.21M | New | 8.59M |
| BELLEVUE GROUP AG | 1.17M | 1.17M | New | 8.28M |
| VIVO CAPITAL, LLC | 1.17M | 1.17M | New | 8.28M |
Aura Biosciences, Inc. (AURA) trades at $6.40, with a market cap of $663.71M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Insights · Dividends · Forecast · Financials · Learn
$663.71M
Market Cap
—
P/E
—
Forward P/E
—
Score